Aquestive Therapeutics Inc share price logo

Aquestive Therapeutics Inc Share Price

NASDAQ: AQST

Small Cap

$4.83

-0.04

(-0.92%)

as on

Aquestive Therapeutics Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $4.78
    $4.97
    downward going graph

    1.04%

    Downside

    2.90%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.12
    $5.8
    downward going graph

    56.11%

    Downside

    20.08%

    Upside

    downward going graph

Aquestive Therapeutics Inc share price movements today

Previous Close
$4.87
Open
$4.88
Volume
1.1M
Day's Low - High
$4.78 - $4.97
52 Week Low - High
$2.12 - $5.8

Aquestive Therapeutics Inc Historical Returns

1 Month Return
+ 22.97 %
3 Month Return
+ 51.18 %
1 Year Return
+ 3.84 %
3 Year Return
+ 317.89 %
5 Year Return
-43.2 %

Aquestive Therapeutics Inc Stock Fundamentals & Key Indicators

Check Aquestive Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$584.3M

EPS (TTM)

-0.58

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-15.58

Industry PE ratio

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-52.0M

Revenue (TTM)

44.1M

Profit Margin

-147.38%

Return On Equity TTM

33801800.00%

Aquestive Therapeutics Inc Stock Valuation

Track how Aquestive Therapeutics Inc P/E has moved over time to understand its valuation trends.

Aquestive Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 18, 2025

Industry (0.00x)

September 18, 2025

Today (-15.58x)

September 18, 2025

Highest (-0.82x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -15.58x

Aquestive Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aquestive Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$584.3M-43.2%-15.58-147.38%
BUY$18.3BNA15.7540.36%
BUY$42.0BNA20.8913.81%
BUY$14.2B40.41%42.2313.88%
BUY$65.1B-8.67%25.2927.83%

Stock Returns calculator for Aquestive Therapeutics Inc Stock including INR - Dollar returns

The Aquestive Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Aquestive Therapeutics Inc investment value today

Current value as on today

₹1,02,174

Returns

₹2,174

(+2.17%)

Returns from Aquestive Therapeutics Inc Stock

₹2,424 (-2.42%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Aquestive Therapeutics Inc Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Aquestive Therapeutics Inc. Average target price of $8.78

Aquestive Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Aquestive Therapeutics Inc.

What analysts predicted

44.99%UPSIDE

Target Price

$8.78

Current Price

$4.83

Analyzed by

14 Analysts

Target

$8.78

Aquestive Therapeutics Inc target price $8.78, a slight upside of 44.99% compared to current price of $4.83. According to 14 analysts rating.

Aquestive Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Aquestive Therapeutics Inc Stock has increased by 880% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:880% versus previous 30 day period

Aquestive Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
11
13
13
13
12
20
13
11
8
10
Gross Profit
6
6
8
8
7
15
9
7
5
5
Operating Income
9
-4
-2
-3
-8
0
-8
-13
-19
-11
EBITDA
9
-3
0
-4
-8
1
-7
-12
-15
-9
Interest Expense
1
1
1
3
4
4
4
4
4
4
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
8
-5
-2
-8
-12
-2
-11
-17
-22
-13
Income Tax Expense
-11
0
0
0
0
-
-
0
-
-
Net Income
19
-5
-2
-8
-12
-2
-11
-17
-22
-13
Net Profit Margin
173.40%
-43.74%
-15.65%
-61.42%
-106.43%
-13.66%
-84.99%
-143.72%
-262.96%
-135.44%

Aquestive Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2006
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
2
51
66
67
52
45
50
47
50
57
Gross Profit
1
35
47
46
32
32
35
28
29
39
Operating Income
-12
0
0
-48
-52
-42
-34
-42
-15
-30
EBITDA
-
2
2
-50
-53
-39
-45
-39
1
-26
Interest Expense
-
6
7
7
9
13
22
12
7
16
Depreciation
-
-
3
3
2
3
2
2
1
0
Income Before Tax
-12
-9
-8
-61
-66
-55
-70
-54
-7
-44
Income Tax Expense
-
6
7
-4
6
9
19
5
0
0
Net Income
-12
-9
-8
-61
-66
-55
-70
-54
-7
-44
Net Profit Margin
-469.69%
-18.54%
-13.36%
-91.02%
-125.92%
-121.67%
-138.77%
-114.11%
-15.56%
-76.68%

Aquestive Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-5
-2
-8
-12
-2
-11
-17
-22
-13
Operating Cash Flow
-7
-2
-4
-10
-7
-11
-6
-23
-7
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
4
4
3
81
1
0
0
20
0
Change in Cash
-4
2
-1
71
-5
-11
-6
-2
-8

Aquestive Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-9
-8
-61
-66
-55
-70
-54
-7
-44
Operating Cash Flow
-8
5
-12
-60
-45
-32
-9
-6
-35
Investing Cash Flow
0
-2
-1
0
0
0
-2
0
0
Financing Cash Flow
5
4
58
49
28
30
11
3
83
Change in Cash
-2
8
43
-11
-17
-3
0
-3
47

Global Institutional Holdings in Aquestive Therapeutics Inc

Funds
Holdings
Bratton Capital Management, L.P.
9.88%
BlackRock Inc
5.98%
Vanguard Group Inc
4.1%
Perceptive Advisors LLC
3.75%
Geode Capital Management, LLC
1.71%

Insights on Aquestive Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, AQST stock has moved up by 75.6%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, AQST has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 8.72M → 10.00M (in $), with an average increase of 12.8% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -22.93M → -13.54M (in $), with an average increase of 69.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Neurocrine Biosciences Inc. has given 19.1% return, outperforming this stock by 21.5%

About Aquestive Therapeutics Inc

aquestive therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives. our team asks questions and identifies issues others have not, and builds solutions that empower patients and their caregivers with better ways to manage complex diseases. our initial focus, supported by our current approved products and late stage pipeline, is to address immediate cns challenges.
OrganisationAquestive Therapeutics Inc
Headquarters30 Technology Drive, Warren, NJ, United States, 07059
IndustryHealth Technology
CEOMr. Daniel Barber
E-voting on sharesClick here to vote

Key Management of Aquestive Therapeutics Inc

Name

Title

Mr. Robert Charles Arnold

VP of Finance, Controller & Assistant Secretary

Ms. Cassie Jung

Chief Operating Officer

Mr. Peter E. Boyd

Senior Vice President of Information Technology & Human Resources

Dr. Gary H. Slatko M.D., MBA

Chief Medical Officer

Dr. Carl N. Kraus M.D.

Chief Medical Officer

Dr. Melina T. Cioffi Pharm.D.

Senior Vice President of Regulatory Affairs

Mr. Daniel Barber

CEO, President & Director

Ms. Lori J. Braender BSBA, Esq., J.D.

Chief Legal Officer, Chief Compliance Officer & Secretary

Mr. A. Ernest Toth Jr.

Chief Financial Officer

Ms. Sherry Korczynski

Chief Commercial Officer

FAQs

What is Aquestive Therapeutics Inc share price today?

Aquestive Therapeutics Inc share price today is $4.83 as on at the close of the market. Aquestive Therapeutics Inc share today touched a day high of $4.97 and a low of $4.78.

What is the 52 week high and 52 week low for Aquestive Therapeutics Inc share?

Aquestive Therapeutics Inc share touched a 52 week high of $5.8 on and a 52 week low of $2.12 on . Aquestive Therapeutics Inc stock price today i.e. is closed at $4.83,which is 16.72% down from its 52 week high and 127.83% up from its 52 week low.

What is Aquestive Therapeutics Inc's market capitalisation today?

Aquestive Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Aquestive Therapeutics Inc Stock (AQST) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Aquestive Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aquestive Therapeutics Inc Shares that will get you 0.3106 shares as per Aquestive Therapeutics Inc share price of $4.83 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Aquestive Therapeutics Inc Stock (AQST) from India?

Indian investors can start investing in Aquestive Therapeutics Inc (AQST) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Aquestive Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Aquestive Therapeutics Inc share’s latest price of $4.83 as on September 18, 2025 at 1:29 am IST, you will get 2.0704 shares of Aquestive Therapeutics Inc. Learn more about fractional shares .

What are the returns that Aquestive Therapeutics Inc has given to Indian investors in the last 5 years?

Aquestive Therapeutics Inc stock has given -43.2% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?